| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer
1 company
Bruce Turner last filed a Form 4 in August 2024, as Chief Strategy Officer at IMNM. Bruce Turner's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 42,300 shares of IMNM. Net of sales, the IMNM filings show accumulation of 42,300 shares.
Bruce Turner has 2 Form 4 filings on record from October 2023 to August 2024, all as Chief Strategy Officer at Immunome (IMNM), 2023–2024.
The 2 reported transactions were 1 option or other derivative award and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $250K and no sales.
The only open-market purchase was 42,300 shares of IMNM at an average $5.91 on October 2, 2023, about $250K. Twelve months later IMNM was up 65%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 | IMNM Immunome Inc. | Chief Strategy Officer | Buy | 42,300 | $5.91 | $249,993.00 | New | +34.3% | +64.9% |